Drug intelligence / Profile preview

Alocross

Development stage
Unknown
Lead developer
Santen Pharmaceutical
Administration
Ophthalmic
01

Overview

Alocross is an over‑the‑counter lubricating ophthalmic solution and gel based on cross‑linked hyaluronic acid and aloe vera, marketed as a CE‑marked medical device for the symptomatic treatment of dry eye disease, ocular discomfort, irritation, and redness caused by environmental or iatrogenic factors.[1][5][6][7][9][11] Cross‑linked hyaluronic acid provides high viscoelasticity, prolonged retention on the ocular surface, and enhanced hydration and lubrication, thereby relieving symptoms of dry eye and protecting the corneal and conjunctival epithelium.[1][5][6][8][11] Aloe vera contributes additional moisturizing, decongestant, and lubricating effects, improving wettability, comfort, and a feeling of ocular freshness, and is particularly useful for reddened or sensitive eyes and for ocular surface disorders induced by chronic topical therapies such as antiglaucoma drops.[1][6][8] Alocross is available in multidose bottles and single‑dose vials, and can be used with contact lenses and after ocular surgery for ongoing symptomatic relief.[1][3][6][7][9][11]

Brand names
Alocross
Other names
Alocross gelAlocross Soluzione OftalmicaAlocross eye dropsAlocross Ophthalmic SolutionAlocross Single-dose Ophthalmic Solution

Beyond the preview

Go deeper on Alocross.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alocross.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call